News from respicardia, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 10, 2019, 08:05 ET Treatment Benefits of the remedē® System Sustained Through 36 Months in Patients with Central Sleep Apnea

Respicardia, Inc., the manufacturer of the only FDA-approved active implantable device for the treatment of central sleep apnea (CSA), today...

Nov 05, 2018, 08:04 ET CMS Grants Outpatient Pass-through Payment to the remedē® System for the Treatment of Central Sleep Apnea

Respicardia, Inc. announced today that the Centers for Medicare and Medicaid Services (CMS) has approved an outpatient Transitional Pass-through...

Aug 06, 2018, 09:59 ET CMS Grants New Technology Add-on Payment to the remedē® System for the Treatment of Central Sleep Apnea

Respicardia, Inc., a medical technology company developing innovative therapies that improve cardiovascular health, today announced that the Centers...

Feb 02, 2018, 07:00 ET Respicardia Announces First U.S. Commercial Case With The remedē® System

Respicardia, Inc., a medical technology company developing innovative therapies that improve cardiovascular health, announced today that the first...

Dec 18, 2017, 06:00 ET Respicardia Closes $58.5 Million In Financing To Treat Central Sleep Apnea

Respicardia, Inc., a private medical technology company, announced today that the company has closed a $58.5 million financing, led by ZOLL Medical...

Oct 10, 2017, 09:53 ET Respicardia's remedē® System Receives FDA Approval

Respicardia, Inc., a private medical technology company, announced today that it received U.S. Food and Drug Administration (FDA) approval of its...

Mar 12, 2014, 11:37 ET Respicardia rafle le prix de la meilleure innovation dans le domaine cardiovasculaire

Respicardia®, Inc., fabricant de dispositifs implantables visant à améliorer la santé cardiovasculaire et respiratoire, a annoncé avoir remporté le...

Mar 12, 2014, 07:03 ET Respicardia erhält Auszeichnung für Top-Innovation im kardiovaskulären Bereich

Respicardia®, Inc., ein Entwickler implantierbarer Behandlungslösungen für die Verbesserung der respiratorischen und kardiovaskulären Gesundheit, gab ...

Mar 12, 2014, 07:03 ET Respicardia Receives Award For Top Cardiovascular Innovation

Respicardia®, Inc., a developer of implantable therapies to improve respiratory and cardiovascular health, announced that it has been awarded the...

Oct 16, 2013, 07:03 ET Respicardia, Inc. Receives the 2013 Acquisition International Finance Award for U.S. Healthcare Product of the Year

Respicardia®, Inc., a developer of implantable therapies to improve respiratory and cardiovascular health, announced that it has been awarded the U.S....

Apr 30, 2013, 07:04 ET Respicardia® Receives FDA Approval to Begin the Pivotal Trial of the remede® System for the Treatment of Central Sleep Apnea

Respicardia, Inc., a developer of implantable therapies to improve respiratory and cardiovascular health, announced it has received approval from the ...